- Home
- EOT vs ATAI Comparison
EOT vs ATAI Comparison
Compare EOT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOT
- ATAI
- Stock Information
- Founded
- EOT 2009
- ATAI 2018
- Country
- EOT United States
- ATAI Germany
- Employees
- EOT N/A
- ATAI N/A
- Industry
- EOT Investment Bankers/Brokers/Service
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- EOT Finance
- ATAI Health Care
- Exchange
- EOT Nasdaq
- ATAI Nasdaq
- Market Cap
- EOT 253.3M
- ATAI 282.6M
- IPO Year
- EOT N/A
- ATAI 2021
- Fundamental
- Price
- EOT $16.75
- ATAI $1.39
- Analyst Decision
- EOT
- ATAI Strong Buy
- Analyst Count
- EOT 0
- ATAI 3
- Target Price
- EOT N/A
- ATAI $10.50
- AVG Volume (30 Days)
- EOT 38.7K
- ATAI 1.3M
- Earning Date
- EOT 01-01-0001
- ATAI 05-19-2025
- Dividend Yield
- EOT 4.51%
- ATAI N/A
- EPS Growth
- EOT N/A
- ATAI N/A
- EPS
- EOT N/A
- ATAI N/A
- Revenue
- EOT N/A
- ATAI $308,000.00
- Revenue This Year
- EOT N/A
- ATAI $65.58
- Revenue Next Year
- EOT N/A
- ATAI N/A
- P/E Ratio
- EOT N/A
- ATAI N/A
- Revenue Growth
- EOT N/A
- ATAI N/A
- 52 Week Low
- EOT $14.63
- ATAI $1.03
- 52 Week High
- EOT $18.30
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- EOT 58.10
- ATAI 46.46
- Support Level
- EOT $16.43
- ATAI $1.29
- Resistance Level
- EOT $16.90
- ATAI $1.54
- Average True Range (ATR)
- EOT 0.29
- ATAI 0.09
- MACD
- EOT 0.06
- ATAI -0.00
- Stochastic Oscillator
- EOT 78.63
- ATAI 37.04
About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST
Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. It invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.